MARGARET BLOCK M.D. NPI 1184604118

NPI Details

Margaret Block, M.D. is a hematology and oncology internal medicine in Omaha, NE with 50 years of experience. The provider is an internist doctor of osteopathy that specializes in the treatment of the combination of hematology and oncology disorders. A doctor of osteopathy that is board eligible/certified by the American Osteopathic Board of Internal Medicine WAS able to obtain a Certificate of Special Qualifications in the field of Hematology and Oncology. The Certificate is NO longer offered. Margaret Block, M.D. NPI is 1184604118. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a female.

Education
Medical School: ALBANY MEDICAL COLLEGE OF UNION UNIVERSITY
Graduation Year:1976

The provider's business location address is:

7500 MERCY RD
SUITE 1300
OMAHA, NE
ZIP 68124-319
Phone: (402) 393-3110
Fax: (402) 393-4499

The NPI 1184604118 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, ferric carboxymaltose, 1 mg (HCPCS:J1439)
• Injection, filgrastim-sndz, biosimilar, (zarxio), 1 microgram (HCPCS:Q5101)
• Injection, darbepoetin alfa, 1 microgram (non-esrd use) (HCPCS:J0881)
• Injection, fosaprepitant, 1 mg (HCPCS:J1453)
• Injection, pembrolizumab, 1 mg (HCPCS:J9271)
• Injection, daratumumab, 10 mg and hyaluronidase-fihj (HCPCS:J9144)
• Injection, paclitaxel, 1 mg (HCPCS:J9267)
• Injection, denosumab, 1 mg (HCPCS:J0897)
• Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• Injection, bortezomib (velcade), 0.1 mg (HCPCS:J9041)
• Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg (HCPCS:J1569)
• Blood test, comprehensive group of blood chemicals (HCPCS:80053)
• Injection, ondansetron hydrochloride, per 1 mg (HCPCS:J2405)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Injection, magnesium sulfate, per 500 mg (HCPCS:J3475)
• Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
• Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 (HCPCS:86300)
• Injection of additional new drug or substance into vein (HCPCS:96375)
• Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
• Injection, pegfilgrastim, excludes biosimilar, 0.5 mg (HCPCS:J2506)
• Injection, potassium chloride, per 2 meq (HCPCS:J3480)
• Cyclophosphamide, 100 mg (HCPCS:J9070)
• Injection, doxorubicin hydrochloride, 10 mg (HCPCS:J9000)
• Flow cytometry technique for dna or cell analysis, each additional marker (HCPCS:88185)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg (HCPCS:J9201)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
• Lactate dehydrogenase (enzyme) level (HCPCS:83615)
• Magnesium level (HCPCS:83735)
• Blood test, basic group of blood chemicals (calcium, total) (HCPCS:80048)
• Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
• Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
• Injection, carboplatin, 50 mg (HCPCS:J9045)
• Carcinoembryonic antigen (cea) protein level (HCPCS:82378)
• Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
• Ferritin (blood protein) level (HCPCS:82728)
• Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
• Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
• Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
• Unclassified drugs (HCPCS:J3490)
• Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
• Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
• Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional (HCPCS:99211)
• Thyroxine (thyroid chemical), free (HCPCS:84439)
• Follow-up hospital inpatient care per day, typically 25 minutes (HCPCS:99232)
• Infusion into a vein for hydration, each additional hour (HCPCS:96361)
• Injection, tixagevimab and cilgavimab, for the pre-exposure prophylaxis only, for certain adults and pediatric individuals (12 years of age and older weighing at least 40kg) with no known sars-cov-2 exposure, who either have moderate to severely compromise (HCPCS:M0220)
• Injection, zoledronic acid, 1 mg (HCPCS:J3489)
• Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
• Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
• Collection of blood sample from implanted device (HCPCS:36591)
• Cortisol (hormone) measurement, total (HCPCS:82533)
• Leuprolide acetate (for depot suspension), 7.5 mg (HCPCS:J9217)
• Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen (HCPCS:87635)
• Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
• Administration of influenza virus vaccine (HCPCS:G0008)
• Urinalysis, manual test (HCPCS:81002)
• Influenza vaccine split virus, preservative free (HCPCS:90662)
• Application of on-body injector for under skin injection (HCPCS:96377)
• Administration of additional new drug or substance into vein using push technique (HCPCS:96411)
• Injection of drug or substance into vein (HCPCS:96374)
• Liver function blood test panel (HCPCS:80076)
• Beta-2 microglobulin (protein) level (HCPCS:82232)
• Psa (prostate specific antigen) measurement, total (HCPCS:84153)
• Detection test by immunoassay with direct visual observation for influenza virus (HCPCS:87804)
• New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
• Irrigation of implanted venous access drug delivery device (HCPCS:96523)
• Flow cytometry technique for dna or cell analysis, first marker (HCPCS:88184)
• Initial hospital inpatient care per day, typically 70 minutes (HCPCS:99223)

The enumeration date for this NPI number is 1/17/2006 and was last updated on 7/19/2012.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.